U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H3N5O2S3
Molecular Weight 261.305
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Halicin

SMILES

NC1=NN=C(SC2=NC=C(S2)[N+]([O-])=O)S1

InChI

InChIKey=NQQBNZBOOHHVQP-UHFFFAOYSA-N
InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8)

HIDE SMILES / InChI

Molecular Formula C5H3N5O2S3
Molecular Weight 261.305
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.7 µM [IC50]
PubMed

PubMed

TitleDatePubMed
Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase.
2009-04-09
Substance Class Chemical
Created
by admin
on Wed Apr 02 08:44:16 GMT 2025
Edited
by admin
on Wed Apr 02 08:44:16 GMT 2025
Record UNII
Y4KQC5P9B2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SU-3327
Preferred Name English
Halicin
Common Name English
5-[(5-Nitro-2-thiazolyl)thio]-1,3,4-thiadiazol-2-amine
Systematic Name English
1,3,4-Thiadiazol-2-amine, 5-[(5-nitro-2-thiazolyl)thio]-
Systematic Name English
SU3327
Code English
Code System Code Type Description
EPA CompTox
DTXSID70474254
Created by admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
PRIMARY
CAS
40045-50-9
Created by admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
PRIMARY
FDA UNII
Y4KQC5P9B2
Created by admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
PRIMARY
PUBCHEM
11837140
Created by admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
PRIMARY
WIKIPEDIA
Halicin
Created by admin on Wed Apr 02 08:44:16 GMT 2025 , Edited by admin on Wed Apr 02 08:44:16 GMT 2025
PRIMARY
Related Record Type Details
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Retained bactericidal activity against antibiotic-tolerant E. coli and M. tuberculosis, as well as growth inhibitory properties against multidrug resistant Gram-negative clinical isolates. Dissipates the DpH Component of the Proton Motive Force